Individuals with inflammatory bowel disease (IBD) experience higher rates of Clostridium difficile infection (CDI) compared with the overall population, often lack typical CDI risk factors, and frequently experience recurrent episodes.1 Despite this, evidence-based management approaches for CDI complicating IBD are lacking.